Recently, Shanghai police cracked down on an illegal drug recycling case in which a pharmaceutical dealer was found to have been systematically purchasing prescription medications at low prices from nearly 20 elderly individuals for resale and profit. The drugs involved were primarily common medications for chronic conditions—such as antihypertensives and hypoglycemics—that beneficiaries obtained at reduced costs through health insurance coverage. The dealer bought these drugs far below market value and then resold them through unofficial channels at significantly higher prices.Such activities not only disrupt the legal pharmaceutical supply chain but also pose serious public health risks. Recycled medications often lack proper storage conditions—like cold-chain logistics—compromising their efficacy or even causing them to degrade, thereby endangering users’ health. Moreover, this ‘drug recycling’ scheme may involve fraudulent claims against public health insurance funds, undermining the fairness and sustainability of healthcare resources.Experts urge seniors to remain vigilant and avoid selling their personal medications for small financial gains. They also call for stronger drug traceability systems and enhanced oversight of health insurance usage to curb such illegal practices at their source. The suspect has been legally processed, and the investigation is ongoing.
近日，上海警方破获一起非法回收药品案件，一名药贩子被查出长期从近20名老年人手中低价收购处方药，再转卖牟利。这些药品多为慢性病常用药，如降压药、降糖药等，原本由医保报销后价格较低，但药贩子以远低于市场价的价格从老人处回收，再通过非正规渠道高价倒卖，从中获取暴利。此类行为不仅扰乱了药品流通秩序，还存在严重安全隐患。回收药品往往脱离冷链或储存条件不当，药效难以保障，甚至可能变质失效，对使用者健康构成威胁。此外，这种‘回流药’交易也涉嫌骗取医保基金，损害公共医疗资源公平性。专家提醒，老年人应提高警惕，切勿因小利出售个人药品；同时呼吁完善药品追溯体系和医保监管机制，从源头遏制非法收药行为。目前，涉案人员已被依法处理，案件仍在进一步调查中。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/1458.html